Fullinsdorf, Switzerland

Jean-Daniel Bonny

This inventor holds 2 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2006.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Jean-Daniel Bonny

Introduction

Jean-Daniel Bonny, based in Füllinsdorf, Switzerland, is a notable inventor recognized for his contributions to the pharmaceutical industry. With two patents to his name, Bonny has made significant advancements in medication formulation, particularly enhancing the efficiency of drug delivery systems.

Latest Patents

Among Jean-Daniel Bonny's latest innovations is the combined capsule and tablets invention. This groundbreaking patent represents a synthesis of capsule and tablet technology, aiming to streamline the process of drug administration for patients. His inventive approach is poised to improve patient compliance and effectiveness in treatment delivery.

Career Highlights

Jean-Daniel Bonny currently holds a position at Novartis AG, a leading global healthcare company. His work is focused on developing innovative solutions that bridge the gap between complex pharmaceutical formulations and practical applications in everyday healthcare settings.

Collaborations

Throughout his career, Bonny has collaborated with distinguished professionals in the field, including his coworkers Stefan Hirsch and Oskar Michael Kalb. These collaborations have fostered an environment of creativity and innovation, furthering advancements in pharmaceutical technology.

Conclusion

Jean-Daniel Bonny continues to make strides in the world of pharmaceuticals, contributing valuable inventions that enhance patient care. His work at Novartis AG, complemented by successful collaborations, underscores his role as a significant innovator in the industry. With his current patents, he is set to impact the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…